Indication |
For production of local or regional anesthesia by infiltration
techniques such as percutaneous injection and intravenous regional
anesthesia by peripheral nerve block techniques such as brachial plexus
and intercostal and by central neural techniques such as lumbar and
caudal epidural blocks. |
Pharmacodynamics |
Dibucaine is an amide-type local anesthetic, similar to lidocaine. |
Mechanism of action |
Local anesthetics block both the initiation and conduction of
nerve impulses by decreasing the neuronal membrane's permeability to
sodium ions through sodium channel inhibition. This reversibly
stabilizes the membrane and inhibits depolarization, resulting in the
failure of a propagated action potential and subsequent conduction
blockade. |
Absorption |
In general, ionized forms (salts) of local anesthetics are not
readily absorbed through intact skin. However, both nonionized (bases)
and ionized forms of local anesthetics are readily absorbed through
traumatized or abraded skin into the systemic circulation. |
Volume of distribution |
Not Available |
Protein binding |
Not Available |
Metabolism |
Primarily hepatic. |
Route of elimination |
Not Available |
Half life |
Not Available |
Clearance |
Not Available |
Toxicity |
Subcutaneous LD50 in rat is 27 mg/kg. Symptoms of overdose include convulsions, hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest. |
Comments
Post a Comment